Pharmaceuticals, Paxil | featured news

GlaxoSmithKline to pay $750 million in pill case

GlaxoSmithKline to pay $750 million in pill case

Federal prosecutors in Massachusetts say pharmaceutical company GlaxoSmithKline will pay $750 million to settle allegations that it knowingly manufactured and sold adulterated drugs at its plant in Puerto Rico, including the popular antidepressant Paxil.

 

Subscribe to this RSS topic: Syndicate content